Scripps Conference – Arrhythmias and Cardiomyopathy in Women Symposium 2026 (Videos)
Advanced Women’s Cardiovascular Medicine, Electrophysiology & Preventive Cardiology Update
Overview
Scripps Arrhythmias and Cardiomyopathy in Women Symposium 2026 is a specialized cardiovascular education program dedicated to the recognition, prevention, diagnosis, and treatment of heart disease uniquely affecting women. This evidence-based symposium provides comprehensive updates on cardiac arrhythmias, cardiomyopathy, heart failure, preventive cardiology, reproductive cardiovascular health, and emerging therapies designed to improve outcomes for women across the cardiovascular care spectrum.
Held on February 28, 2026, at the Westin Carlsbad Resort & Spa, California, the symposium brings together leading experts in cardiology, electrophysiology, heart failure, women’s cardiovascular health, preventive medicine, and cardio-oncology. The program addresses persistent gender disparities in cardiovascular diagnosis and treatment while providing practical, guideline-based strategies for managing cardiovascular disease in women.
Through expert lectures, clinical case discussions, and evidence-based reviews, participants gain valuable insights into sex-specific cardiovascular risk factors, atypical disease presentations, pregnancy-associated cardiovascular disorders, menopause-related cardiovascular changes, microvascular disease, and cardiotoxicity in cancer survivors.
Course Specifications
- Format: Video Recordings
- Course Date: February 28, 2026
- Location: Carlsbad, California, USA
- Access: On-Demand
- Level: Intermediate to Advanced
- Educational Focus: Women’s Cardiovascular Medicine, Electrophysiology & Preventive Cardiology
Course Overview
Cardiovascular disease remains the leading cause of death among women worldwide. Despite significant advances in cardiovascular care, women continue to experience delayed diagnosis, under-recognition of symptoms, treatment disparities, and unique cardiovascular challenges related to hormonal, reproductive, and oncologic factors.
The Arrhythmias and Cardiomyopathy in Women Symposium 2026 focuses on:
- Sex-specific cardiovascular disease patterns
- Cardiac arrhythmias in women
- Cardiomyopathy and heart failure
- Preventive cardiology
- Menopause and hormone-related cardiovascular changes
- Pregnancy-associated cardiovascular disorders
- Coronary microvascular dysfunction
- Cardio-oncology and survivorship care
The curriculum emphasizes practical application of contemporary guidelines, individualized risk assessment, and emerging therapies that can improve long-term cardiovascular outcomes for female patients.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Discuss cardiovascular conditions that are more prevalent or unique to women.
- Recognize atypical presentations of cardiovascular disease and arrhythmias in women.
- Evaluate disparities in the utilization of evidence-based cardiovascular therapies.
- Assess modern lipid-lowering therapies and obesity medications for cardiovascular risk reduction.
- Apply current approaches to the diagnosis and management of heart failure in women.
- Understand menopause-related cardiovascular risk changes and hormone replacement therapy considerations.
- Describe management strategies for cardiovascular disease during pregnancy.
- Recognize microvascular disease and endothelial dysfunction in women with angina.
- Evaluate cardiovascular complications in breast cancer survivors and oncology patients.
- Develop individualized cardiovascular prevention strategies for women.
Major Topics Covered
Arrhythmias in Women
Sex-Specific Electrophysiology
- Gender differences in arrhythmia presentation
- Hormonal influences on cardiac rhythm
- Female-specific electrophysiologic considerations
Clinical Recognition
- Atypical symptom presentation
- Delayed diagnosis challenges
- Sex-related differences in disease progression
Advanced Arrhythmia Management
- Pharmacologic therapy
- Catheter ablation strategies
- Device therapy considerations
Treatment Disparities
- Underutilization of therapies
- Barriers to care
- Evidence-based treatment optimization
Cardiomyopathy & Heart Failure in Women
Heart Failure in Female Patients
- HFrEF and HFpEF
- Sex-specific risk factors
- Early recognition strategies
Cardiomyopathy
- Dilated cardiomyopathy
- Peripartum cardiomyopathy
- Inflammatory cardiomyopathies
Advanced Heart Failure Management
- Guideline-directed medical therapy
- Individualized treatment strategies
- Long-term outcome optimization
Hormonal Influences
- Estrogen and cardiovascular function
- Cardiovascular aging
- Sex-related pathophysiologic mechanisms
Preventive Cardiology
Cardiovascular Risk Reduction
- Primary prevention
- Secondary prevention
- Risk stratification in women
Advanced Lipid Management
- LDL reduction strategies
- Lipoprotein(a)
- Personalized prevention plans
Emerging Lipid Therapies
- PCSK9 inhibitors
- Novel lipid-lowering agents
- Combination treatment approaches
Obesity Medicine & Cardiovascular Risk
Obesity and Heart Disease
- Cardiometabolic risk assessment
- Weight-related cardiovascular disease
Modern Obesity Therapies
- GLP-1 receptor agonists
- Emerging metabolic treatments
- Long-term cardiovascular benefits
Lifestyle Medicine
- Nutrition
- Exercise strategies
- Behavioral modification approaches
Menopause & Hormonal Cardiovascular Health
Menopause and Cardiovascular Risk
- Vascular aging
- Metabolic changes
- Endothelial dysfunction
Hormone Replacement Therapy (HRT)
- Current evidence
- Risks and benefits
- Patient selection considerations
Individualized Care
- Risk stratification
- Counseling strategies
- Long-term monitoring
Pregnancy & Cardiovascular Disease
High-Risk Pregnancy
- Cardiovascular risk assessment
- Maternal hemodynamic adaptation
- Pregnancy-associated complications
Pregnancy-Related Cardiac Conditions
- Arrhythmias during pregnancy
- Peripartum cardiomyopathy
- Hypertensive disorders of pregnancy
Multidisciplinary Care
- Cardio-obstetrics
- Maternal-fetal collaboration
- Postpartum cardiovascular follow-up
Coronary Microvascular Disease & Endothelial Dysfunction
Ischemia Without Obstructive Coronary Disease
- INOCA
- Coronary microvascular dysfunction
- Angina with non-obstructive coronary arteries
Endothelial Dysfunction
- Pathophysiology
- Diagnostic strategies
- Treatment approaches
Diagnostic Challenges
- Atypical presentations
- Delayed diagnosis
- Risk assessment beyond angiography
Cardio-Oncology & Breast Cancer Survivorship
Cardiovascular Toxicity
- Chemotherapy-induced cardiotoxicity
- Radiation-associated heart disease
- Long-term cardiovascular complications
Breast Cancer Survivorship
- Cardiac surveillance
- Prevention strategies
- Long-term cardiovascular care
Collaborative Care Models
- Cardio-oncology programs
- Multidisciplinary treatment planning
- Survivorship management
Educational Features
✔ Women-focused cardiovascular medicine curriculum
✔ Advanced electrophysiology and arrhythmia updates
✔ Heart failure and cardiomyopathy education
✔ Preventive cardiology and lipid management reviews
✔ Menopause and hormone-related cardiovascular health discussions
✔ Pregnancy and cardio-obstetrics education
✔ Microvascular disease and endothelial dysfunction updates
✔ Cardio-oncology and survivorship care strategies
✔ Evidence-based guideline reviews
✔ Practical clinical application and case discussions
Who Should Attend?
This course is ideal for:
- Cardiologists
- Electrophysiologists
- Heart Failure Specialists
- Preventive Cardiologists
- Internal Medicine Physicians
- Women’s Health Specialists
- Obstetricians and Maternal-Fetal Medicine Specialists
- Cardio-Oncology Providers
- Nurse Practitioners
- Physician Assistants
- Cardiology Fellows
- Residents
- Advanced Practice Providers
Why This Course Stands Out
✔ Dedicated exclusively to cardiovascular disease in women
✔ Addresses under-recognized and sex-specific conditions
✔ Strong focus on preventive cardiology
✔ Comprehensive arrhythmia and heart failure education
✔ Includes menopause, pregnancy, and hormonal health topics
✔ Covers emerging therapies including GLP-1 medications
✔ Reviews microvascular disease and endothelial dysfunction
✔ Integrates cardio-oncology and survivorship care
✔ Evidence-based and clinically practical
✔ Highly relevant to modern cardiovascular practice
Product Details
Course: Scripps Arrhythmias and Cardiomyopathy in Women Symposium 2026
Format: Video Recordings
Course Date: February 28, 2026
Location: Carlsbad, California
Level: Intermediate to Advanced
Educational Focus: Women’s Cardiovascular Medicine, Electrophysiology, Heart Failure & Preventive Cardiology
